ArticleDigital health
Developing and testing a smoking cessation app in Arabic language: A pilot randomized trial study protocol.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06766227 (Developing a Smoking Cessation Mobile App. in Arabic), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Developing a Smoking Cessation Mobile App. in Arabic: A Pilot Randomized Trial for Efficacy.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tobacco consumption in the Middle East is very high. Many smoking cessation apps effectively reduce smoking rates, yet few smoking cessation apps are tailored to the region. To date, smoking cessation apps in Arabic are mostly translated from English, with no studies assessing their efficacy. Additionally, these apps often fail to address cultural differences. The purpose of this study is to develop a smoking cessation app in Arabic (iEndSmokin, Method: In this pilot randomized trial, adults who smoke will be randomized and allocated in a 1:1 ratio to either the app intervention group (using the app) or the control group. Participants in the control arm will attend educational sessions. The intervention will last for 3 months, and participants will be followed for 6 months. A total of 200 adults who smoke willing to quit will be recruited between October and November 2025 (or until recruitment is complete). The study will run from December 2025 to May 2026, with follow-ups at baseline, 1 month, 3 months, and 6 months. Data will be analyzed using an intention-to-treat approach. Results: The primary outcome will be 30-day point prevalence of smoking abstinence with biochemically confirmed cessation via normal saliva cotinine levels at 3 months. Secondary outcomes include either a 7-day point prevalence abstinence verified by saliva cotinine levels, and a ≥ 20% reduction in smoking rate. Long-term abstinence will be assessed at 6 months' post-intervention. Conclusion: Developing a culturally sensitive smoking cessation app to be available for the majority of adults who smoke for free that adhere to clinical guideline is a promising low-cost solution to promote behavioral change. We hypothesize that the iEndSmokin App will be an effective, accessible, and feasible smoking cessation tool for Arabic-speaking populations.Clinical Trial Registration: ClinicalTrials.gov Identifier: NCT06766227.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.